Instruction CSP Perfusion sets

Cardioplegic solution administration sets – five design options for blood and crystalloid cardioplegia during operations with сardiopulmonary bypass

Instruction

CSP Perfusion sets

Home

Download instruction (PDF)

01

General information

CSP perfusion sets are cardioplegic solution administration sets designed to deliver cardioplegia during cardiac surgery with сardiopulmonary bypass. Each component is designed for safety—from the air trap to the universal connectors for the oxygenator and roller pumps

Characteristics of the CSP delivery systems

Select a version to view the set contents

02

Scope of application

For use by trained medical personnel in healthcare settings

Field of application: transfusiology

TypeMI: 191430 "Set for administration of cardioplegic solution"

The medical device is sterile, single-use, category A (less than 24 hours), indirectly contacts the bloodstream

Risk class 2a

03

Purpose

Delivery of a cardioplegic solution to protect the heart from ischemia and reperfusion injury. The method (hypothermic, moderately hypothermic, normothermic, blood, or crystalloid) is determined by the treatment plan. This product is single-use, non-toxic, non-pyrogenic, and sterilized with ethylene oxide.

Design options

The choice of one method or another is determined by the type of cardioplegia

CSP.1 - for delivery of normothermic and moderately hypothermic blood cardioplegic solution

CSP.2 is similar to KSF.1, except for the built-in heat exchanger, which is used to cool the blood cardioplegic perfusate

CSP.3 is similar to KSF.1, but supports only a single cardioplegic solution container connection

CSP.4 - for crystalloid cardioplegia, does not contain a blood supply line

CSP.6 - is similar to KSF.4 in composition and purpose, except that it accommodates only one cardioplegic solution container

04

Indications and contraindications

Indications

Cardiac surgery with сardiopulmonary bypass and on a clamped aorta

Contraindications

Dissection of vessels depending on the area of perfusion

Side effects

Postperfusion syndrome

Insufficient anticoagulation → obstruction of the extracorporeal circuit and the patient circuit, which can lead to hemolysis, thrombus formation

05

Operating procedure

1

It's important to check the expiration date and the packaging for leaks. When removing the line from the packaging, it's important to observe aseptic technique.

2

Next, connect the silicone tubing of the common cardioplegia line to the roller pumps of the cardioplegia attachment. For blood cardioplegia, the line is connected to both roller pumps (options KSF.1, KSF.2, KSF.3); for crystalloid cardioplegia, the line isconnected to only one roller pump (options KSF.4 and KSF.6).

3

The common cardioplegia line is connected to the main solution container using a two-channel polymer needle (or, if necessary, to an additional container in the KSF.1, KSF.2, and KSF.4 variants). In the case of blood cardioplegia (KSF.1, KSF.2, and KSF.3), the blood supply line is connected to the coronary perfusion port of the oxygenator via a connector (1/4" x 1/16" connecting tube). The port and tube ends are pre-treated with an antiseptic solution. The line is then filled with perfusate.

4

After the line is filled and air is removed, the roller pumps are stopped and a clamp is applied to the main line. If necessary, connect an external invasive pressure monitoring line.

5

Remove the solution supply line from the bag, connect it to the main line, turn on the roller pumps, and fill the lines with the mixture, removing any air bubbles. Clamp the end of the solution supply line.

6

The cardiac surgeon connects the solution supply line to the cardioplegic cannula and removes air bubbles.

7

To administer cardioplegia, remove the clamp from the line and turn on the roller pump at a speed in accordance with the selected technique.

8

At the end of cardioplegia, a clamp is applied to the line leading to the cannula and the roller pumps are stopped.